Women’s health is a growing field of innovation, with more attention being given to maternal care and prenatal health in recent years. Technology is now playing a pivotal role in advancing pregnancy care by providing expectant mothers with better access to crucial health services. The global femtech industry, which focuses on using technology to improve women’s healthcare, is expected to reach $1 trillion by 2027. Biorithm, a Singapore-based startup, is positioning itself at the forefront of this movement by offering mobile technology that enhances pregnancy monitoring and care for mothers worldwide.
A New Approach to Maternity Care
Biorithm was co-founded by Amrish Nair, who serves as the company’s chief technology officer, alongside a team of doctors and engineers who recognized a significant gap in the innovation of women’s healthcare. Despite advancements in medicine, pregnancy care has largely remained unchanged for decades.
Nair and his team sought to change this by creating a maternity care platform that would cater to the modern needs of expectant women. Thus, Biorithm launched Femom, a platform that enables clinicians to provide care to mothers and their babies remotely.
Femom allows pregnant women to monitor their health from home, eliminating the need for frequent hospital visits while providing valuable data to healthcare professionals. This remote care is especially important in reducing preventable poor outcomes in pregnancy, a key goal of Biorithm. By leveraging data science and mobile technology, the startup aims to provide accessible, timely care to mothers, wherever they may be.
Bridging Gaps in Maternal Health
With maternal and newborn deaths still occurring at alarming rates globally, Biorithm aims to address this issue by making pregnancy care more convenient and accessible. Femom’s remote monitoring capabilities allow expectant mothers to track their health and their baby’s development in real time. Clinicians can access this data, ensuring that any potential complications are identified early, leading to timely interventions that improve outcomes.
Biorithm’s technology is especially beneficial for women in rural or underserved areas, where access to quality maternity care may be limited. By bringing healthcare to the mother’s home, Femom removes the barriers that often prevent women from receiving the care they need. This solution not only enhances patient convenience but also provides peace of mind, knowing that their health is being closely monitored by medical professionals without requiring frequent in-person visits.
The Future of Biorithm
Looking ahead, Biorithm has ambitious plans for growth. As the femtech industry continues to evolve, the startup aims to expand its reach to more countries and healthcare systems. Nair and his team are focused on continuously improving the Femom platform to ensure that it can serve a wider range of mothers and healthcare providers. Their mission is clear: to make maternal healthcare more accessible and reduce preventable maternal and newborn deaths worldwide.
As Biorithm continues to develop its technology, the company is gaining attention from investors who recognize the potential for scalable, impactful change in the maternity care space. By addressing critical gaps in maternal health, Biorithm is poised to make a significant contribution to the future of women’s healthcare, one pregnancy at a time.
To read more startup stories visit- singaporebusinessedge.
